This is somewhat in contrast to reports of a biphasic response in MCI and AD patients as measured by the monoamine oxidase B inhibitor PET ligand (11C-deuterium-l-deprenyl; DED), which is supportive of an early upregulation and later decline of astrogliosis [38, 72]. This evidence concerns the gene MAOB and Alzheimer disease.